WoundSource Section Logos - White Papers

Defying the Recalcitrant Wound: A New Approach

Defying the Recalcitrant Wound - A New Approach
 

Chronic wounds are increasingly recognized as a global public health issue. In the United States alone, there are an estimated 6.5 million chronic wounds, each with a high annual treatment cost. Because chronic wound incidence increases significantly with age and the world population over 60 years of age is growing, wound prevention and early management have become key objectives.

Initial wound prevention and management measures typically concentrate on treating the underlying associated disease process and exudate management but often neglect to address imbalances in the wound bed, such as persistent bioburden. New evidence-based technology is now available in the form of a topical dressing that tackles wound bed alterations seen in both acute and chronic wounds and promotes healing.

This well-illustrated and extensively referenced white paper written for wound care professionals provides an in-depth look at wound chronicity, discusses bioburden management, and introduces a topical dressing that supports an effective antibiotic stewardship program.

The following topics are discussed:

Epidemiology and costs of chronic wounds
Chronic wound characteristics and factors predisposing to chronicity
Wound exudate and the healing process
Bioburden as a precursor in infection
Wound bioburden continuum
Antimicrobial resistance and antibiotic stewardship
Management of chronic wound infection
Antibiotics versus antiseptics
AQUACEL™ Ag Advantage dressing (Hydrofiber™, ionic silver, ethylenediaminetetra-acetic acid, and benzethonium chloride): mechanism of action and evidence base

This white paper is generally written for health care professionals with an interest in product solutions.

Sponsored by ConvaTec

Chronic wounds are increasingly recognized as a global public health issue. In the United States alone, there are an estimated 6.5 million chronic wounds, each with a high annual treatment cost. Because chronic wound incidence increases significantly with age and the world population over 60 years of age is growing, wound prevention and early management have become key objectives.

Initial wound prevention and management measures typically concentrate on treating the underlying associated disease process and exudate management but often neglect to address imbalances in the wound bed, such as persistent bioburden. New evidence-based technology is now available in the form of a topical dressing that tackles wound bed alterations seen in both acute and chronic wounds and promotes healing.

This well-illustrated and extensively referenced white paper written for wound care professionals provides an in-depth look at wound chronicity, discusses bioburden management, and introduces a topical dressing that supports an effective antibiotic stewardship program.

The following topics are discussed:

Epidemiology and costs of chronic wounds
Chronic wound characteristics and factors predisposing to chronicity
Wound exudate and the healing process
Bioburden as a precursor in infection
Wound bioburden continuum
Antimicrobial resistance and antibiotic stewardship
Management of chronic wound infection
Antibiotics versus antiseptics
AQUACEL™ Ag Advantage dressing (Hydrofiber™, ionic silver, ethylenediaminetetra-acetic acid, and benzethonium chloride): mechanism of action and evidence base

This white paper is generally written for health care professionals with an interest in product solutions.

Sponsored by ConvaTec

WoundSource
The World’s Definitive Source for Wound Care & Product Information